Wells Fargo analyst issues OVERWEIGHT recommendation for WTW on February 4, 2026 11:22AM ET. The previous analyst recommendation was Overweight.WTW was trading at $335.1 at issue of the analyst recommendation.The...
Wells Fargo analyst issues OVERWEIGHT recommendation for TTWO on February 4, 2026 11:25AM ET. The previous analyst recommendation was Overweight.TTWO was trading at $212.17 at issue of the analyst recommendation.The...
Wells Fargo analyst issues OVERWEIGHT recommendation for BALL on February 4, 2026 11:26AM ET. The previous analyst recommendation was Overweight.BALL was trading at $61.77 at issue of the analyst recommendation.The...
UBS analyst issues NEUTRAL recommendation for MDLZ on February 4, 2026 11:31AM ET. The previous analyst recommendation was Neutral.MDLZ was trading at $59.47 at issue of the analyst recommendation.The overall...
Wells Fargo analyst issues OVERWEIGHT recommendation for HUBB on February 4, 2026 11:28AM ET. The previous analyst recommendation was Overweight.HUBB was trading at $503.86 at issue of the analyst recommendation.The...
UBS analyst issues BUY recommendation for FDX on February 4, 2026 11:29AM ET. The previous analyst recommendation was Buy.FDX was trading at $353.43 at issue of the analyst recommendation.The overall...
Wells Fargo analyst issues POSITIVE recommendation for EMR on February 4, 2026 11:31AM ET. The previous analyst recommendation was Positive.EMR was trading at $152.1 at issue of the analyst recommendation.The...
UBS analyst issues BUY recommendation for DVA on February 4, 2026 11:34AM ET. The previous analyst recommendation was Buy.DVA was trading at $134.73 at issue of the analyst recommendation.The overall...
Citigroup analyst issues NEUTRAL recommendation for ATKR on February 4, 2026 11:34AM ET. The previous analyst recommendation was Neutral.ATKR was trading at $69.89 at issue of the analyst recommendation.The overall...
Citigroup analyst issues BUY recommendation for EMR on February 4, 2026 11:35AM ET. The previous analyst recommendation was Buy.EMR was trading at $152.1 at issue of the analyst recommendation.The overall...
